Related Experiment Video

Updated: Sep 2, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Exisulind, a selective apoptotic antineoplastic drug

E T Goluboff1

  • 1Department of Urology and Comprehensive Cancer Center, School of Medicine, Columbia-Presbyterian Medical Center, New York, USA. eg45@columbia.edu

Expert Opinion on Investigational Drugs
|January 5, 2002
PubMed

Insights

Exisulind, a novel pro-apoptotic drug, effectively targets cancer cells by activating protein kinase G (PKG), leading to programmed cell death. Clinical studies show promise in preventing colorectal polyps and inhibiting prostate cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Exisulind is a novel targeted pro-apoptotic drug.
  • It selectively induces apoptosis in cancerous tissues via protein kinase G (PKG) activation.
  • This mechanism offers a new approach to cancer treatment.

Purpose of the Study:

  • To evaluate the antineoplastic effects of exisulind.
  • To assess its efficacy in preclinical cancer models and clinical trials.
  • To explore its potential as a monotherapy or in combination treatments.

Main Methods:

  • Preclinical studies in cancer cell lines and rodent models.
  • Clinical trials in patients with familial adenomatous polyposis (FAP) and prostate cancer.
  • Evaluation of exisulind's effect on tumor growth and specific biomarkers (e.g., PSA).

Main Results:

  • Exisulind demonstrated antineoplastic activity in various solid and hematological cancer cell lines.
  • It inhibited tumor growth in multiple rodent cancer models.
  • Clinical studies showed exisulind prevented colorectal polyp formation and slowed PSA progression in prostate cancer patients.

Conclusions:

  • Exisulind exhibits significant preclinical and early clinical antineoplastic activity.
  • Its pro-apoptotic mechanism and safety profile suggest broad therapeutic potential.
  • Exisulind may be effective as a monotherapy or in combination with chemotherapy and other targeted agents.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...